Karyopharm Therap (KPTI.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov3

Karyopharm Therap released FY2025 Q3 earnings on November 3 Pre-Market EST, actual revenue USD 44.04 M (forecast USD 42.41 M), actual EPS USD -3.8213 (forecast USD -3.5226)

14:30

Karyopharm Therapeutics released FY2025 9 Months Earnings on November 3 Pre-Market (EST), actual revenue USD 67.94 M, actual EPS USD -7.0915

14:30

Oct27

Karyopharm Therap to Release FY2025 Q3 Earnings on November 3, Pre-Market EST; Forecast Revenue USD 42.41M, EPS USD -3.5226

00:05

Oct10

Abrahams Maintains Karyopharm Therapeutics' Stock Rating

01:56

Oct9

Analyst Tenthoff Covers Healthcare Industry and Focuses on Specific Stocks

11:12

Aug11

Karyopharm Therapeutics released FY2025 Q2 earnings on August 11 After-Market EST, actual revenue USD 37.93 M (forecast USD 37.93 M), actual EPS USD -4.3215 (forecast USD -4.03)

23:00